|国家科技期刊平台
首页|期刊导航|中国药理学通报|8-型磷酸二酯酶抑制剂PF-04957325对冈田酸诱导阿尔茨海默病小鼠认知障碍的改善作用及机制

8-型磷酸二酯酶抑制剂PF-04957325对冈田酸诱导阿尔茨海默病小鼠认知障碍的改善作用及机制OA北大核心CSTPCD

Improvement and mechanism of PF-04957325,an 8-type phosphodiesterase inhibitor,in cognitive impairment induced by okadaic acid in mice with Alzheimer's disease

中文摘要英文摘要

目的 探讨磷酸二酷酶8(phosphodiesterase 8,PDE8)抑制剂PF-04957325对冈田酸(okadaic acid,OA)诱导阿尔茨海默病(Alzheimer's disease,AD)小鼠学习记忆、焦虑、抑郁的影响,并对其机制进行初步探讨.方法 选取21只2月龄雄性C57BL/6J小鼠进行实验,随机分为对照组、AD模型组、PDE8抑制剂组(0.1 mg·kg-1).模型组和PDE8抑制剂组小鼠双侧海马定位注射OA(每侧50 ng)诱导AD模型,注射OA2 d后,PDE8抑制剂组给予0.1 mg·kg-1抑制剂,AD模型组和对照组给予等剂量溶剂,共给药21 d.给予抑制剂d 13,对小鼠学习记忆能力及焦虑抑郁行为进行相关行为学检测,HE染色观察小鼠海马DG、CA1、CA3区神经细胞形态,Western blot检测小鼠海马内不同位点磷酸化Tau蛋白水平以及PDE8/cAMP/CREB通路相关蛋白的表达.结果 与对照组相比,AD模型组Y迷宫轮替比、新物体识别指数、被动回避逃避潜伏期明显缩短(P<0.01),水迷宫穿越平台次数及在目标象限停留的时间减少(P<0.05),表现出学习记忆能力的下降,而给予PF-04957325可明显改善AD小鼠学习记忆能力;AD模型组进入旷场中央区次数及在中央区停留时间明显减少(P<0.05)、悬尾不动时间明显增加(P<0.01),提示小鼠有焦虑抑郁情况,给予PF-04957325 后小鼠焦虑行为没有得到改善,对抑郁行为有一定改善;AD模型组小鼠海马DG、CA1、CA3区表现出核仁固缩、神经元排列不整齐,给予PF-04957325可缓解小鼠海马神经细胞的损伤.与对照组相比,AD模型组小鼠海马中Tau蛋白Ser199、Ser396和Ser202位点的磷酸化水平明显升高(P<0.01)、PDE8A及PDE8B蛋白表达量明显增加(P<0.01)、p-PKA/PKA和BDNF蛋白表达量降低(P<0.05),给予PF-04957325后Tau蛋白Ser396和Ser202位点的磷酸化水平明显降低(P<0.01)、PDE8A和PDE8B蛋白表达量明显降低(P<0.01)、p-PKA/PKA、p-CREB/CREB 和 BDNF蛋白表达量明显升高(P<0.01).结论 PDE8抑制剂PF-04957325 能够提高AD小鼠的学习记忆能力、降低认知功能障碍,恢复Tau蛋白功能,减轻AD小鼠海马内神经元细胞的损害,具有改善AD的作用.作用机制可能与激活PDE8/cAMP/CREB通路、抑制Tau蛋白磷酸化有关.

Aim To investigate the effects of the phos-phodiesterase 8(PDE8)inhibitor PF-04957325 on learning and memory,anxiety and depression in Alzhe-imer's disease(AD)mice induced by Okadaic acid(OA),and to explore its mechanism.Methods Twenty-one 2-month-old male C57BL/6J mice were se-lected for the experiment and randomly divided into the control group,AD model group,and PDE8 inhibitor group(0.1 mg·kg-1).AD model was induced by bi-lateral hippocampal localization injection of OA(50 ng on each side)in the model and PDE8 inhibitor groups of mice.Two days after the injection of OA,PDE8 in-hibitor group was given 0.1 mg·kg-1 drug,while the AD model groups and control group were given with the same volume of vehicle for 21 consecutive days.On day 13 of inhibitor administration,behavioral tests re-lated to learning and memory abilities,anxiety and de-pressive behaviors were performed in mice.HE stai-ning was used to observe the morphology of neuronal cells in the DG,CA1,and CA3 regions of the hippo-campus of mice,and Western blot was used to detect the levels of phosphorylated Tau proteins at different sites within the hippocampus of mice as well as the ex-pression of proteins related to the PDE8/cAMP/CREB pathway.Results Compared with the control group,the Y-maze Spontaneous alternation,Recognition index of NOR and Latency of PAT were significantly shorter(P<0.01),and Entries times、Time in the target quadrant of MWM were reduced(P<0.05)in the AD model group,which showed a decrease in the ability of learning and memory,whereas the administration of PF-04957325 significantly improved the ability of learning and memory in the AD mice;mice in the AD model group showed a significant decrease in the num-ber of entries into the central area of the OFT and the time spent in the central area(P<0.05),and a sig-nificant increase in the Immobility time of TST(P<0.01),suggesting that the mice had anxiety and de-pression,and the administration of PF-04957325 did not improve the anxious behavior of the mice,but im-proved the depressed behavior to a certain extent;the hippocampus of the AD model group mice showed ker-nel solidification in the DG,CA1 and CA3 regions,and neurons were not neatly arranged,and the admin-istration of PF-04957325 could alleviate the damage of hippocampal nerve cells in mice.Compared with the control group,the phosphorylation levels of Tau protein Ser1 99,Ser396 and Ser202 sites in the hippocampus of mice in the AD model group were significantly in-creased(P<0.01),the expression of PDE8A and PDE8B proteins was significantly increased(P<0.01),and the expression of p-PKA/PKA and BDNF proteins was decreased(P<0.05),after administra-tion of PF-04957325,the phosphorylation levels of Tau protein Ser396 and Ser202 sites were significantly re-duced(P<0.01),PDE8A and PDE8B protein ex-pression was significantly decreased(P<0.01),and p-PKA/PKA,p-CREB/CREB and BDNF protein ex-pression was significantly increased(P<0.01).Con-clusion PDE8 inhibitor PF-04957325 can improve learning memory ability,reduce cognitive dysfunction,restore Tau protein function,and attenuate neuronal cell damage in the hippocampus of AD mice with amel-iorative effects.The mechanism of action may be relat-ed to the activation of PDE8/cAMP/CREB pathway and inhibition of Tau protein phosphorylation.

吕玉丽;郭天洋;仇念壮;张汉霆;王浩

山东第一医科大学药理学研究所,山东泰安 271016山东第一医科大学药理学研究所,山东泰安 271016||青岛大学药学院药理教研室,山东青岛 266073

磷酸二酯酶PDE8抑制剂阿尔茨海默病学习记忆Tau蛋白冈田酸

phosphodiesterasePDE8 inhibitorAlzheimer's diseaselearning and memoryTau pro-teinOkadaic acid

《中国药理学通报》 2024 (009)

1719-1726 / 8

国家自然科学基金资助项目(No 82073827)

10.12360/CPB202403053

评论